Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients.

Vascular pharmacology - 1 Feb 2022

Akbari Mohammadarian, Taheri Mohammad, Mehrpoor Golbarg, Eslami Solat, Hussen Bashdar Mahmud, Ghafouri-Fard Soudeh, Arefian Noormohammad

Abstract excerpt

Contribution of the renin-angiotensinogen system in the risk of COVID-19 and related complications have been assessed by several groups. However, the results are not consistent. We examined levels of ACE1 and ACE2 in the circulation of two groups of COVID-19 patients (ICU-admitted and general ward-admitted patients) compared with healthy controls. We also genotyped two polymorphisms in ACE1 gene (the ACE1-I/D...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Apelin-related biomedical research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Genotype

Share to Peptidyl-Dipeptidase A

Share to Polymorphism, Genetic

Share to Renin-Angiotensin System Studies

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 34774774
DOI: 10.1016/j.vph.2021.106934
PMCID: PMC8579741

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients.PMID 34774774Read ↗

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.Semantic proximity Read ↗

The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control studySemantic proximity Read ↗

Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 diseaseSemantic proximity Read ↗

The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients.Semantic proximity Read ↗

Angiotensin-converting enzyme (<i>ACE1, ACE2</i>) gene variants are associated with COVID19 severity depending on the hypertension statusSemantic proximity Read ↗

The effect of angiotensin-converting enzyme insertion/deletion polymorphism on severity and death rate of COVID-19 in Iranian patientsSemantic proximity Read ↗

Role of ACE, ACE2 gene variants and serum ACE/ACE2 ratio in COVID-19 severitySemantic proximity Read ↗

ACE polymorphism and COVID-19 outcomeSemantic proximity Read ↗

COVID-19 infections are also affected by human ACE1 D/I polymorphismSemantic proximity Read ↗

Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients.Semantic proximity Read ↗

Angiotensin-Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 Symptoms.Semantic proximity Read ↗

ACE polymorphisms and COVID-19-related mortality in EuropeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.